Summary & Overview
CPT 4115F: Preoperative Beta Blocker Administration for CABG
CPT code 4115F denotes administration of a beta blocker within 24 hours before coronary artery bypass graft (CABG) surgery. This preoperative medication entry records a targeted perioperative intervention intended to optimize hemodynamics and myocardial oxygen demand before major cardiac surgery. Nationally, accurate reporting of this measure is relevant for perioperative quality monitoring, surgical care pathways, and performance measurement tied to cardiac surgical outcomes.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for perioperative beta blocker use, the service setting and workflow implications, and where this code typically appears on the claim. The publication outlines common benchmarking use cases and policy considerations affecting measurement and documentation for preoperative medication reporting. It also highlights practical coding and billing contexts in which the code is applied and notes when input data are not available for specific ancillary fields.
This summary is intended for a national audience of clinicians, coding professionals, quality officers, and payer policy staff who need a clear, compact reference to the purpose and use of CPT code 4115F in CABG surgical care.
Billing Code Overview
CPT code 4115F reports administration of a beta blocker within 24 hours before coronary artery bypass graft (CABG) surgery. The code documents that the provider gave a beta-adrenergic blocking medication in the day leading up to the operative procedure to help open blood vessels and improve blood flow.
-
Service type: Preoperative medication administration
-
Typical site of service: Inpatient hospital setting or preoperative surgical unit where CABG surgery is performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 67-year-old male with multivessel coronary artery disease is scheduled for elective coronary artery bypass graft (CABG) surgery. Preoperative evaluation in the cardiothoracic surgery clinic documents a history of hypertension, hyperlipidemia, and prior myocardial infarction. The anesthesia and surgical teams coordinate perioperative medications. As part of standard preoperative optimization, the anesthesia or surgical team administers a beta blocker within 24 hours before the operation to reduce perioperative myocardial ischemia and control heart rate and blood pressure. Documentation includes the beta blocker name, dose, route, time of administration relative to incision, the clinician administering the medication, and the indication (e.g., perioperative heart rate control prior to coronary artery bypass graft surgery). The administration is reported using 4115F when the patient received the beta blocker within the specified 24-hour preoperative window. Typical site of service is an inpatient hospital preoperative unit, preoperative holding area, or operating room/anesthesia pre-induction area. Providers involved commonly include cardiothoracic surgeons, anesthesiologists, and preoperative nursing staff working within hospital-based surgical services.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated Evaluation and Management service by the same physician during a postoperative period |